These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36418519)

  • 1. Early experience of robotic axillary lymph node dissection in patients with node-positive breast cancer.
    Ahn JH; Park JM; Choi SB; Go J; Lee J; Kim JY; Park HS
    Breast Cancer Res Treat; 2023 Apr; 198(3):405-412. PubMed ID: 36418519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the utility of robotic axillary lymph node dissection in patients with invasive breast cancer: a systematic review.
    Thornton R; Davey MG; Kerin MJ
    Ir J Med Sci; 2024 Jun; 193(3):1163-1170. PubMed ID: 37971673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
    Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
    Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contemporary Axillary Management in cT1-2N0 Breast Cancer with One or Two Positive Sentinel Lymph Nodes: Factors Associated with Completion Axillary Lymph Node Dissection Within the National Cancer Database.
    Stafford AP; Hoskin TL; Day CN; Sanders SB; Boughey JC
    Ann Surg Oncol; 2022 Aug; 29(8):4740-4749. PubMed ID: 35451727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analyzing non-sentinel axillary metastases in patients with T3-T4 cN0 early breast cancer and tumor-involved sentinel lymph nodes undergoing breast-conserving therapy or mastectomy.
    Riedel F; Heil J; Feisst M; Moderow M; von Au A; Domschke C; Michel L; Schaefgen B; Golatta M; Hennigs A
    Breast Cancer Res Treat; 2020 Nov; 184(2):627-636. PubMed ID: 32816190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
    Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
    Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Women Could Avoid Axillary Lymph Node Dissection by Choosing Breast-Conserving Therapy Instead of Mastectomy.
    Vane MLG; Hunter-Squires J; Kim S; Smidt ML; Giuliano AE
    Ann Surg Oncol; 2021 May; 28(5):2522-2528. PubMed ID: 33586070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Population-Based Study of the Effects of a Regional Guideline for Completion Axillary Lymph Node Dissection on Axillary Surgery in Patients with Breast Cancer.
    Tsao MW; Cornacchi SD; Hodgson N; Simunovic M; Thabane L; Cheng J; O'Brien MA; Strang B; Mukherjee SD; Lovrics PJ
    Ann Surg Oncol; 2016 Oct; 23(10):3354-64. PubMed ID: 27342830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted axillary dissection with preoperative tattooing of biopsied positive axillary lymph nodes in breast cancer.
    Gatek J; Petru V; Kosac P; Ratajsky M; Duben J; Dudesek B; Jancik P; Zabojnikova M; Katrusak J; Opelova P; Podrazska L; Vazan P; Kudlova P; Holik P; Melichar B; Vrana D
    Neoplasma; 2020 Nov; 67(6):1329-1334. PubMed ID: 32749847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of the Use of Completion Axillary Lymph Node Dissection in Patients with T1/2N0M0 Breast Cancer and Tumour-Involved Sentinel Lymph Nodes Undergoing Mastectomy: A Cohort Study.
    Hennigs A; Riedel F; Feißt M; Köpke M; Rezai M; Nitz U; Moderow M; Golatta M; Sohn C; Heil J
    Ann Surg Oncol; 2019 Aug; 26(8):2435-2443. PubMed ID: 31049766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial experience with sentinel node biopsy in breast cancer at the National Cancer Center Hospital East.
    Imoto S; Hasebe T
    Jpn J Clin Oncol; 1999 Jan; 29(1):11-5. PubMed ID: 10073145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Which patients with sentinel node-positive breast cancer after breast conservation still receive completion axillary lymph node dissection in routine clinical practice?
    Hennigs A; Köpke M; Feißt M; Riedel F; Rezai M; Nitz U; Moderow M; Golatta M; Sohn C; Schneeweiss A; Heil J
    Breast Cancer Res Treat; 2019 Jan; 173(2):429-438. PubMed ID: 30315437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subsequent axillary surgery after sentinel lymph node biopsy: results from the BreastSurgANZ Quality Audit 2006-2010.
    Chong C; Walters D; de Silva P; Taylor C; Spillane A; Kollias J; Pyke C; Campbell I; Maddern G
    Breast; 2013 Dec; 22(6):1215-9. PubMed ID: 24157405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Influence of Hospital and Surgeon Factors on the Prevalence of Axillary Lymph Node Evaluation in Ductal Carcinoma In Situ.
    Coromilas EJ; Wright JD; Huang Y; Feldman S; Neugut AI; Chen L; Hershman DL
    JAMA Oncol; 2015 Jun; 1(3):323-32. PubMed ID: 26181180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast of Mastoscopic and Conventional Axillary Lymph Node Dissection of Patients With Breast Cancer: Meta-Analysis.
    Xiong H; Chen Z; Xu L; Chen C; Fu Q; Teng R; Chen J; Xie S; Wang L; Yu XF; Zhou J
    Cancer Control; 2020; 27(2):1073274820932987. PubMed ID: 32602366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors that determine whether a patient receives completion axillary lymph node dissection after a positive sentinel lymph node biopsy for breast cancer in British Columbia.
    Aslani N; Swanson T; Kennecke H; Woods R; Davis N
    Can J Surg; 2011 Aug; 54(4):237-42. PubMed ID: 21651836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer patients with extra-axillary sentinel nodes only may be spared axillary lymph node dissection.
    van der Ploeg IM; Tanis PJ; Valdés Olmos RA; Kroon BB; Rutgers EJ; Nieweg OE
    Ann Surg Oncol; 2008 Nov; 15(11):3239-43. PubMed ID: 18773244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of completion axillary lymph node dissection in patients with positive sentinel lymph nodes.
    Karam AK; Hsu M; Patil S; Stempel M; Traina TA; Ho AY; Cody HS; Port ER; Morrow M; Gemignani ML
    Ann Surg Oncol; 2009 Jul; 16(7):1952-8. PubMed ID: 19381724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A positive intramammary lymph node does not mandate a complete axillary node dissection.
    Diaz R; Degnim AC; Boughey JC; Nassar A; Jakub JW
    Am J Surg; 2012 Feb; 203(2):151-5. PubMed ID: 21788008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing Observation, Axillary Radiotherapy, and Completion Axillary Lymph Node Dissection for Management of Axilla in Breast Cancer in Patients with Positive Sentinel Nodes: A Systematic Review.
    Castelo M; Hu SY; Dossa F; Acuna SA; Scheer AS
    Ann Surg Oncol; 2020 Aug; 27(8):2664-2676. PubMed ID: 32020394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.